Exploring how snake toxins interact with human receptors related to Alzheimer's disease

Identifying the Interactions between Animal Toxins and Human nAChRs: The Role of Snake PLA2 in Interacting with nAChR alpha Subunits

NIH-funded research University of Texas Rio Grande Valley · NIH-10818654

This study is looking at how certain snake toxins interact with important receptors in our bodies that help with brain functions, which could lead to new insights for understanding conditions like Alzheimer's disease.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Rio Grande Valley NIH-funded
Lab location1 site (Edinburg, United States)
Project IDNIH-10818654 on NIH RePORTER

What this research studies

This research investigates the interactions between animal toxins, specifically from snakes, and human nicotinic acetylcholine receptors (nAChRs), which are crucial for various physiological processes. The study aims to identify specific snake toxins that can bind to different nAChR subunits, potentially revealing new insights into their structure and function. By utilizing high-throughput methods, researchers will generate a library of snake toxins and analyze their effects on human nAChRs, which may help in understanding disorders like Alzheimer's disease. This approach leverages the natural specificity of snake toxins to advance our knowledge of receptor interactions.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.

Not a fit: Patients with other forms of dementia not related to nAChR dysfunction may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating Alzheimer's disease and related disorders.

How similar studies have performed: While the use of animal toxins to study human receptors is a novel approach, similar methodologies have shown promise in other areas of receptor research.

Where this research is happening

Edinburg, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.